Company Filing History:

9 out of 237

Banyu Pharmaceutical Co. Ltd

patents

Taisho Pharmaceutical Co., Ltd.

patents

4. 1 out of 1,235

Nissan Chemical Industries Limited

patents

where one patent can have more than one assignee

Years Active: 2007-2015

Loading Chart...

15 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 9035059 - Nitrogen-containing condensed heterocyclic compound (2015-05-19),

2. 8822503 - 2-pyridone compounds (2014-09-02),

3. 8268842 - Fused ring 4-oxopyrimidine derivative (2012-09-18),

4. 8158652 - Substituted pyridone derivative (2012-04-17),

5. 8138206 - Piperidine derivative (2012-03-20),

6. 8044070 - Heteroaryloxy nitrogenous saturated heterocyclic derivative (2011-10-25),

7. 7960402 - Carbamoyl-substituted spiro derivative (2011-06-14),

8. 7960394 - Quinazoline derivative (2011-06-14),

9. 7834182 - Piperidine derivative (2010-11-16),

10. 7790731 - Crystal form of 2-methyl-3-{4-[3-(1-pyrrolidinyl)propoxy]phenyl}-5-trifluoromethyl-4(3H)-quinazolinone (2010-09-07),

11. 7645756 - Nitrogenous fused heteroaromatic ring derivative (2010-01-12),

12. 7595316 - Heteroaryloxy nitrogenous saturated heterocyclic derivative (2009-09-29),

13. 7547693 - Piperidine derivative (2009-06-16),

14. 7521455 - Fused ring 4-oxopyrimidine derivative (2009-04-21),

15. 7279293 - Constitutively active histamine H3 receptor mutants and uses thereof (2007-10-09),

Title: Shigeru Tokita: Innovator in Pharmaceutical Chemistry

Introduction: Shigeru Tokita, a prominent inventor based in Tsukuba, Japan, has made significant contributions to the field of pharmaceutical chemistry. With a remarkable portfolio of 15 patents, Tokita's work focuses on developing innovative compounds that play crucial roles in drug development and therapeutic applications.

Latest Patents: Among his latest patents, Tokita has developed nitrogen-containing condensed heterocyclic compounds. These compounds are represented by a general formula and are designed to demonstrate superior monoacylglycerol acyltransferase 2 inhibitory action. Additionally, he has created a 2-pyridone compound, which is characterized by a specific structural formula. This compound exhibits excellent glucokinase (GK) activating effects and is considered beneficial for pharmaceutical use.

Career Highlights: Shigeru Tokita's career spans several years in distinguished research roles, particularly at notable companies like Banyu Pharmaceutical Co., Ltd. and MSD K.K. His expertise in synthesizing complex organic compounds has positioned him as a significant figure in the pharmaceutical industry.

Collaborations: Collaborating with other talented researchers, Tokita has worked alongside individuals such as Akio Kanatani and Nagaaki Sato. These collaborations have enriched his research initiatives and contributed to innovative breakthroughs in his field.

Conclusion: Shigeru Tokita's dedication to innovation in pharmaceutical chemistry is evident through his patents and research collaborations. His contributions continue to advance the development of new therapeutic compounds that hold promise for improving healthcare outcomes globally.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

3 patents (CIPO):

Please report any incorrect information to support@idiyas.com

1 patent (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.